nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbutaline—Isoprenaline—MAPK1—melanoma	0.224	0.554	CrCbGaD
Terbutaline—Clenbuterol—TNF—melanoma	0.127	0.314	CrCbGaD
Terbutaline—Epinephrine—TNF—melanoma	0.0531	0.132	CrCbGaD
Terbutaline—Injection site pain—Carmustine—melanoma	0.0139	0.0508	CcSEcCtD
Terbutaline—Chest discomfort—Docetaxel—melanoma	0.00826	0.0301	CcSEcCtD
Terbutaline—Flushing—Bleomycin—melanoma	0.00607	0.0221	CcSEcCtD
Terbutaline—Hallucination—Carmustine—melanoma	0.00568	0.0207	CcSEcCtD
Terbutaline—Flushing—Dactinomycin—melanoma	0.00566	0.0206	CcSEcCtD
Terbutaline—Asthenia—Vemurafenib—melanoma	0.00551	0.0201	CcSEcCtD
Terbutaline—Hallucination—Temozolomide—melanoma	0.00549	0.02	CcSEcCtD
Terbutaline—Flushing—Carmustine—melanoma	0.0053	0.0193	CcSEcCtD
Terbutaline—Flushing—Temozolomide—melanoma	0.00512	0.0187	CcSEcCtD
Terbutaline—Dizziness—Vemurafenib—melanoma	0.00507	0.0185	CcSEcCtD
Terbutaline—Vomiting—Vemurafenib—melanoma	0.00488	0.0178	CcSEcCtD
Terbutaline—Chest pain—Bleomycin—melanoma	0.00485	0.0177	CcSEcCtD
Terbutaline—Rash—Vemurafenib—melanoma	0.00484	0.0176	CcSEcCtD
Terbutaline—Dermatitis—Vemurafenib—melanoma	0.00483	0.0176	CcSEcCtD
Terbutaline—Headache—Vemurafenib—melanoma	0.00481	0.0175	CcSEcCtD
Terbutaline—Cramp muscle—Docetaxel—melanoma	0.00478	0.0174	CcSEcCtD
Terbutaline—Tremor—Carmustine—melanoma	0.00466	0.017	CcSEcCtD
Terbutaline—Nausea—Vemurafenib—melanoma	0.00456	0.0166	CcSEcCtD
Terbutaline—Tremor—Temozolomide—melanoma	0.0045	0.0164	CcSEcCtD
Terbutaline—Palpitations—Temozolomide—melanoma	0.00425	0.0155	CcSEcCtD
Terbutaline—Chest pain—Carmustine—melanoma	0.00423	0.0154	CcSEcCtD
Terbutaline—Anxiety—Carmustine—melanoma	0.00422	0.0154	CcSEcCtD
Terbutaline—Paraesthesia—Bleomycin—melanoma	0.00417	0.0152	CcSEcCtD
Terbutaline—Dyspnoea—Bleomycin—melanoma	0.00414	0.0151	CcSEcCtD
Terbutaline—Anxiety—Temozolomide—melanoma	0.00408	0.0149	CcSEcCtD
Terbutaline—Dry mouth—Temozolomide—melanoma	0.004	0.0146	CcSEcCtD
Terbutaline—Tachycardia—Carmustine—melanoma	0.00396	0.0144	CcSEcCtD
Terbutaline—Hyperhidrosis—Temozolomide—melanoma	0.00379	0.0138	CcSEcCtD
Terbutaline—Insomnia—Carmustine—melanoma	0.00367	0.0134	CcSEcCtD
Terbutaline—Paraesthesia—Carmustine—melanoma	0.00364	0.0133	CcSEcCtD
Terbutaline—Dyspnoea—Carmustine—melanoma	0.00362	0.0132	CcSEcCtD
Terbutaline—Somnolence—Carmustine—melanoma	0.00361	0.0131	CcSEcCtD
Terbutaline—Insomnia—Temozolomide—melanoma	0.00355	0.0129	CcSEcCtD
Terbutaline—Paraesthesia—Temozolomide—melanoma	0.00352	0.0128	CcSEcCtD
Terbutaline—Dyspnoea—Temozolomide—melanoma	0.0035	0.0127	CcSEcCtD
Terbutaline—Somnolence—Temozolomide—melanoma	0.00349	0.0127	CcSEcCtD
Terbutaline—Flushing—Docetaxel—melanoma	0.00341	0.0124	CcSEcCtD
Terbutaline—Asthenia—Bleomycin—melanoma	0.00334	0.0122	CcSEcCtD
Terbutaline—Asthenia—Dactinomycin—melanoma	0.00311	0.0113	CcSEcCtD
Terbutaline—Muscle spasms—Docetaxel—melanoma	0.00307	0.0112	CcSEcCtD
Terbutaline—Vomiting—Bleomycin—melanoma	0.00296	0.0108	CcSEcCtD
Terbutaline—Rash—Bleomycin—melanoma	0.00293	0.0107	CcSEcCtD
Terbutaline—Dermatitis—Bleomycin—melanoma	0.00293	0.0107	CcSEcCtD
Terbutaline—Asthenia—Carmustine—melanoma	0.00291	0.0106	CcSEcCtD
Terbutaline—Palpitations—Docetaxel—melanoma	0.00282	0.0103	CcSEcCtD
Terbutaline—Asthenia—Temozolomide—melanoma	0.00281	0.0102	CcSEcCtD
Terbutaline—Nausea—Bleomycin—melanoma	0.00276	0.0101	CcSEcCtD
Terbutaline—Vomiting—Dactinomycin—melanoma	0.00276	0.01	CcSEcCtD
Terbutaline—Rash—Dactinomycin—melanoma	0.00273	0.00996	CcSEcCtD
Terbutaline—Chest pain—Docetaxel—melanoma	0.00272	0.00991	CcSEcCtD
Terbutaline—Dizziness—Carmustine—melanoma	0.00268	0.00978	CcSEcCtD
Terbutaline—Dry mouth—Docetaxel—melanoma	0.00266	0.00969	CcSEcCtD
Terbutaline—Dizziness—Temozolomide—melanoma	0.00259	0.00945	CcSEcCtD
Terbutaline—Vomiting—Carmustine—melanoma	0.00258	0.0094	CcSEcCtD
Terbutaline—Nausea—Dactinomycin—melanoma	0.00258	0.00938	CcSEcCtD
Terbutaline—Rash—Carmustine—melanoma	0.00256	0.00932	CcSEcCtD
Terbutaline—Dermatitis—Carmustine—melanoma	0.00256	0.00931	CcSEcCtD
Terbutaline—Tachycardia—Docetaxel—melanoma	0.00255	0.00927	CcSEcCtD
Terbutaline—Headache—Carmustine—melanoma	0.00254	0.00926	CcSEcCtD
Terbutaline—Vomiting—Temozolomide—melanoma	0.00249	0.00908	CcSEcCtD
Terbutaline—Rash—Temozolomide—melanoma	0.00247	0.00901	CcSEcCtD
Terbutaline—Dermatitis—Temozolomide—melanoma	0.00247	0.009	CcSEcCtD
Terbutaline—Headache—Temozolomide—melanoma	0.00246	0.00895	CcSEcCtD
Terbutaline—Nausea—Carmustine—melanoma	0.00241	0.00878	CcSEcCtD
Terbutaline—Insomnia—Docetaxel—melanoma	0.00236	0.00859	CcSEcCtD
Terbutaline—Paraesthesia—Docetaxel—melanoma	0.00234	0.00853	CcSEcCtD
Terbutaline—Nausea—Temozolomide—melanoma	0.00233	0.00849	CcSEcCtD
Terbutaline—Dyspnoea—Docetaxel—melanoma	0.00232	0.00847	CcSEcCtD
Terbutaline—Somnolence—Docetaxel—melanoma	0.00232	0.00845	CcSEcCtD
Terbutaline—Asthenia—Docetaxel—melanoma	0.00187	0.00682	CcSEcCtD
Terbutaline—Dizziness—Docetaxel—melanoma	0.00172	0.00628	CcSEcCtD
Terbutaline—Vomiting—Docetaxel—melanoma	0.00166	0.00604	CcSEcCtD
Terbutaline—Rash—Docetaxel—melanoma	0.00164	0.00599	CcSEcCtD
Terbutaline—Dermatitis—Docetaxel—melanoma	0.00164	0.00598	CcSEcCtD
Terbutaline—Headache—Docetaxel—melanoma	0.00163	0.00595	CcSEcCtD
Terbutaline—Nausea—Docetaxel—melanoma	0.00155	0.00564	CcSEcCtD
Terbutaline—BCHE—Peptide hormone metabolism—CTNNB1—melanoma	0.00132	0.0041	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PIK3CG—melanoma	0.00132	0.00409	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.00132	0.00409	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR4—melanoma	0.0013	0.00405	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2R—melanoma	0.0013	0.00403	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRB—melanoma	0.00126	0.00391	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—PRKCA—melanoma	0.00125	0.00388	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ACER3—melanoma	0.00124	0.00385	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CXCR2—melanoma	0.00116	0.00361	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PIK3CD—melanoma	0.00116	0.0036	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—RPS3—melanoma	0.00116	0.00359	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PLCB4—melanoma	0.00115	0.00355	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CXCL1—melanoma	0.00115	0.00355	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—UGT2B10—melanoma	0.00114	0.00353	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—WNT5A—melanoma	0.00113	0.0035	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.00112	0.00348	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR4—melanoma	0.00112	0.00347	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HS3ST5—melanoma	0.00106	0.00328	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CXCL1—melanoma	0.00104	0.00323	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PLCB4—melanoma	0.00104	0.00323	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PIK3CB—melanoma	0.00101	0.00314	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—F2R—melanoma	0.00099	0.00307	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—F2RL1—melanoma	0.000974	0.00302	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—PRKCA—melanoma	0.000959	0.00298	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—EDNRB—melanoma	0.000958	0.00298	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—DRAP1—melanoma	0.000953	0.00296	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MYO7A—melanoma	0.000953	0.00296	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—BRAF—melanoma	0.000921	0.00286	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GRM3—melanoma	0.000915	0.00284	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—F2RL1—melanoma	0.000884	0.00274	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PTEN—melanoma	0.000873	0.00271	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—KISS1—melanoma	0.000868	0.00269	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—melanoma	0.000857	0.00266	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CXCR4—melanoma	0.000851	0.00264	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.00085	0.00264	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CXCR1—melanoma	0.00084	0.00261	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GRM3—melanoma	0.000831	0.00258	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—MC1R—melanoma	0.000828	0.00257	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TAS2R60—melanoma	0.000811	0.00252	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PLCB4—melanoma	0.0008	0.00248	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CCR7—melanoma	0.000794	0.00246	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GRM1—melanoma	0.000794	0.00246	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—KISS1—melanoma	0.000788	0.00245	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000785	0.00244	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—MDM2—melanoma	0.000772	0.0024	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CXCR1—melanoma	0.000763	0.00237	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SLC6A11—melanoma	0.000752	0.00234	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIP4K2A—melanoma	0.000752	0.00234	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—MC1R—melanoma	0.000752	0.00233	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—PAX6—melanoma	0.000738	0.00229	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—MTAP—melanoma	0.000732	0.00227	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—RHOB—melanoma	0.000722	0.00224	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CCR7—melanoma	0.000721	0.00224	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GRM1—melanoma	0.000721	0.00224	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000715	0.00222	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—HSPA5—melanoma	0.000709	0.0022	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—BRAF—melanoma	0.000706	0.00219	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CXCR2—melanoma	0.000658	0.00204	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—RHOB—melanoma	0.000656	0.00204	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—EDN1—melanoma	0.000652	0.00203	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—LUM—melanoma	0.000652	0.00202	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PHGDH—melanoma	0.000652	0.00202	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—RAC2—melanoma	0.000647	0.00201	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HPSE—melanoma	0.00064	0.00199	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CUBN—melanoma	0.000628	0.00195	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PIK3CA—melanoma	0.000616	0.00191	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PLCB4—melanoma	0.000614	0.00191	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCL1—melanoma	0.000614	0.00191	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SDHD—melanoma	0.000606	0.00188	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CSPG4—melanoma	0.000606	0.00188	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—BSG—melanoma	0.000606	0.00188	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CXCR2—melanoma	0.000597	0.00185	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—MDM2—melanoma	0.000591	0.00184	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—RAC2—melanoma	0.000588	0.00182	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GPAM—melanoma	0.000587	0.00182	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—WNT5A—melanoma	0.000578	0.0018	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CUL3—melanoma	0.000578	0.00179	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TRRAP—melanoma	0.000578	0.00179	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AKR1B10—melanoma	0.000562	0.00174	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—F2R—melanoma	0.000559	0.00174	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—EDNRB—melanoma	0.000542	0.00168	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—MAPK1—melanoma	0.000528	0.00164	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—F2RL1—melanoma	0.000522	0.00162	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GNA11—melanoma	0.000511	0.00159	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GAB2—melanoma	0.000511	0.00159	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—F2R—melanoma	0.000508	0.00158	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PLA2G6—melanoma	0.000499	0.00155	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—EDNRB—melanoma	0.000492	0.00153	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GRM3—melanoma	0.000491	0.00152	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CXCR4—melanoma	0.000481	0.00149	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GNAQ—melanoma	0.000475	0.00148	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KISS1—melanoma	0.000466	0.00145	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GNA11—melanoma	0.000464	0.00144	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GAB2—melanoma	0.000464	0.00144	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000463	0.00144	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCR1—melanoma	0.000451	0.0014	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SKI—melanoma	0.000451	0.0014	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—VCAN—melanoma	0.000449	0.00139	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MC1R—melanoma	0.000444	0.00138	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AKT3—melanoma	0.000439	0.00136	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CXCR4—melanoma	0.000437	0.00136	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GNAQ—melanoma	0.000432	0.00134	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCR7—melanoma	0.000426	0.00132	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GRM1—melanoma	0.000426	0.00132	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000425	0.00132	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—HRAS—melanoma	0.000424	0.00131	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—MMP1—melanoma	0.00042	0.0013	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SUFU—melanoma	0.000415	0.00129	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.00041	0.00127	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—MAPK1—melanoma	0.000404	0.00125	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AKT3—melanoma	0.000398	0.00124	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—BCL2L11—melanoma	0.000387	0.0012	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RHOB—melanoma	0.000387	0.0012	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP17A1—melanoma	0.000378	0.00117	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000373	0.00116	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HDAC6—melanoma	0.000372	0.00116	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—EDN1—melanoma	0.000369	0.00114	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—ALB—melanoma	0.000368	0.00114	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CSF2—melanoma	0.00036	0.00112	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GNA11—melanoma	0.000357	0.00111	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCR2—melanoma	0.000353	0.0011	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CXCL8—melanoma	0.000353	0.00109	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—FASN—melanoma	0.00035	0.00109	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RAC2—melanoma	0.000347	0.00108	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PRKCA—melanoma	0.000345	0.00107	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SLC5A5—melanoma	0.000344	0.00107	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—WNT5A—melanoma	0.000342	0.00106	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—VEGFC—melanoma	0.000342	0.00106	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—IGF1—melanoma	0.000336	0.00104	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—EDN1—melanoma	0.000335	0.00104	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CD44—melanoma	0.000332	0.00103	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GNAQ—melanoma	0.000332	0.00103	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CSF2—melanoma	0.000327	0.00102	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.000325	0.00101	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—MMP2—melanoma	0.000325	0.00101	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—HRAS—melanoma	0.000325	0.00101	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000322	0.001	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—RAC1—melanoma	0.00032	0.000994	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP1B1—melanoma	0.000319	0.000989	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PRKCA—melanoma	0.000314	0.000974	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—MAP2K2—melanoma	0.000307	0.000952	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—F2R—melanoma	0.0003	0.000931	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—RAC1—melanoma	0.000291	0.000903	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EDNRB—melanoma	0.000291	0.000902	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTK2B—melanoma	0.000282	0.000876	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000281	0.000873	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GAB2—melanoma	0.000274	0.000852	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GNA11—melanoma	0.000274	0.000852	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FLT1—melanoma	0.000273	0.000848	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CG—melanoma	0.000271	0.00084	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—CXCL8—melanoma	0.00027	0.000839	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ABCB1—melanoma	0.000262	0.000814	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HDAC2—melanoma	0.000258	0.000801	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCR4—melanoma	0.000258	0.000801	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FOXO4—melanoma	0.000258	0.000801	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GNAQ—melanoma	0.000255	0.000792	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—CTNNB1—melanoma	0.000249	0.000774	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CG—melanoma	0.000246	0.000763	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PRKCA—melanoma	0.000241	0.000749	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SYK—melanoma	0.00024	0.000744	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ERCC2—melanoma	0.000239	0.000743	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CD—melanoma	0.000238	0.000738	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AKT3—melanoma	0.000235	0.000731	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NGFR—melanoma	0.000235	0.000731	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ITGAV—melanoma	0.000235	0.000731	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SOCS1—melanoma	0.000218	0.000677	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—MAP2K1—melanoma	0.000217	0.000675	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—S100B—melanoma	0.000217	0.000675	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CD—melanoma	0.000216	0.000671	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ERBB4—melanoma	0.000208	0.000645	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CB—melanoma	0.000207	0.000644	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CDKN2B—melanoma	0.000206	0.00064	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CD86—melanoma	0.000199	0.000619	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CXCL8—melanoma	0.000199	0.000619	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.000198	0.000616	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EDN1—melanoma	0.000198	0.000614	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CSF2—melanoma	0.000193	0.0006	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGF1—melanoma	0.000193	0.0006	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—IL2—melanoma	0.00019	0.000591	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—E2F1—melanoma	0.000189	0.000587	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CG—melanoma	0.000189	0.000587	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CB—melanoma	0.000188	0.000585	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PDGFRA—melanoma	0.000187	0.000581	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ITGB3—melanoma	0.000185	0.000575	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PRKCA—melanoma	0.000185	0.000575	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PPARG—melanoma	0.000183	0.000567	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SPP1—melanoma	0.000182	0.000564	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAP2K2—melanoma	0.000181	0.000562	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CXCL8—melanoma	0.000181	0.000562	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL2—melanoma	0.000173	0.000537	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TERT—melanoma	0.000172	0.000535	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RAC1—melanoma	0.000172	0.000533	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CD—melanoma	0.000166	0.000516	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HIF1A—melanoma	0.000165	0.000512	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ALB—melanoma	0.000164	0.000509	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KDR—melanoma	0.000158	0.000489	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FN1—melanoma	0.000152	0.000471	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NOTCH1—melanoma	0.000148	0.000461	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CD80—melanoma	0.000145	0.000451	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KIT—melanoma	0.000145	0.000451	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—APC—melanoma	0.000145	0.000451	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CG—melanoma	0.000145	0.000451	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—NRAS—melanoma	0.000145	0.000451	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CB—melanoma	0.000145	0.00045	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PTGS2—melanoma	0.000144	0.000446	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EGF—melanoma	0.000143	0.000445	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—MAPK3—melanoma	0.000139	0.000432	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—BRAF—melanoma	0.000136	0.000424	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IGF1—melanoma	0.000133	0.000413	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—MAPK1—melanoma	0.000132	0.000411	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—EGFR—melanoma	0.000132	0.000411	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAP2K1—melanoma	0.000128	0.000399	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CD—melanoma	0.000128	0.000396	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	0.000126	0.000392	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PTEN—melanoma	0.000125	0.000389	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—KRAS—melanoma	0.000125	0.000388	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGF2—melanoma	0.000122	0.000379	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CA—melanoma	0.000115	0.000356	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MDM2—melanoma	0.000114	0.000355	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ERBB2—melanoma	0.000113	0.00035	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CB—melanoma	0.000111	0.000345	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCL8—melanoma	0.000107	0.000332	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—HRAS—melanoma	0.000106	0.00033	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CDKN1B—melanoma	0.000104	0.000324	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AKT1—melanoma	0.000103	0.000321	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CASP3—melanoma	0.000102	0.000318	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL2—melanoma	0.000102	0.000317	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL6—melanoma	0.000102	0.000316	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCND1—melanoma	9.96e-05	0.000309	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CTNNB1—melanoma	9.86e-05	0.000306	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MMP9—melanoma	9.67e-05	0.0003	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CDKN1A—melanoma	9.63e-05	0.000299	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTEN—melanoma	9.61e-05	0.000298	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NFKB1—melanoma	9.57e-05	0.000297	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AKT1—melanoma	9.38e-05	0.000291	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CA—melanoma	8.83e-05	0.000274	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—VEGFA—melanoma	8.68e-05	0.00027	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—STAT3—melanoma	8.6e-05	0.000267	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NRAS—melanoma	8.58e-05	0.000266	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAPK3—melanoma	8.21e-05	0.000255	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MYC—melanoma	7.99e-05	0.000248	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAPK1—melanoma	7.81e-05	0.000243	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EGFR—melanoma	7.81e-05	0.000243	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KRAS—melanoma	7.38e-05	0.000229	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—AKT1—melanoma	7.22e-05	0.000224	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CA—melanoma	6.78e-05	0.00021	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TP53—melanoma	6.56e-05	0.000204	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HRAS—melanoma	6.27e-05	0.000195	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL6—melanoma	6e-05	0.000186	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AKT1—melanoma	5.54e-05	0.000172	CbGpPWpGaD
